                         SEQUENCE LISTING

<110>  Wang, Chang-Yi
       Wen-Jiun, Peng
 
<120>  Immunogenic LHRH composition and use thereof in pigs

<130>  1004263.212WO (2033-WO)

<140>  TBD
<141>  2014-07-25

<160>  12    

<170>  PatentIn version 3.5

<210>  1
<211>  10
<212>  PRT
<213>  Swine


<220>
<221>  PEPTIDE
<222>  (1)..(10)
<223>  LHRH peptide

<400>  1

Glu His Trp Ser Tyr Gly Leu Arg Pro Gly 
1               5                   10  


<210>  2
<211>  17
<212>  PRT
<213>  Swine


<220>
<221>  PEPTIDE
<222>  (1)..(17)
<223>  Tetanus toxin (aa. 830-844)

<400>  2

Lys Lys Gln Tyr Ile Lys Ala Asn Ser Lys Phe Ile Gly Leu Thr Glu 
1               5                   10                  15      


Leu 
    


<210>  3
<211>  17
<212>  PRT
<213>  Swine


<220>
<221>  PEPTIDE
<222>  (1)..(17)
<223>  MVF Th

<400>  3

Leu Ser Glu Ile Lys Gly Val Ile Val His Arg Leu Glu Gly Val Gly 
1               5                   10                  15      


Gly 
    


<210>  4
<211>  15
<212>  PRT
<213>  Swine


<220>
<221>  PEPTIDE
<222>  (1)..(15)
<223>  HBsAg Th

<400>  4

Phe Phe Leu Leu Thr Arg Ile Leu Thr Ile Pro Gln Ser Leu Glu 
1               5                   10                  15  


<210>  5
<211>  19
<212>  PRT
<213>  Swine


<220>
<221>  PEPTIDE
<222>  (1)..(19)
<223>  SSAL1 Th

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  S or T

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  K or R

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  G or T

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  H or T

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  K or R

<400>  5

Ile Ser Ile Xaa Glu Ile Xaa Xaa Val Ile Val Xaa Xaa Ile Glu Thr 
1               5                   10                  15      


Ile Leu Phe 
            


<210>  6
<211>  16
<212>  PRT
<213>  Swine


<220>
<221>  PEPTIDE
<222>  (1)..(16)
<223>  co-stimulatory peptide domain from Invasin

<400>  6

Thr Ala Lys Ser Lys Lys Phe Pro Ser Tyr Thr Ala Thr Tyr Gln Phe 
1               5                   10                  15      


<210>  7
<211>  27
<212>  PRT
<213>  Swine


<220>
<221>  PEPTIDE
<222>  (1)..(17)
<223>  Tetanus toxin Th

<220>
<221>  PEPTIDE
<222>  (18)..(27)
<223>  LHRH

<400>  7

Lys Lys Gln Tyr Ile Lys Ala Asn Ser Lys Phe Ile Gly Ile Thr Glu 
1               5                   10                  15      


Leu Glu His Trp Ser Tyr Gly Leu Arg Pro Gly 
            20                  25          


<210>  8
<211>  45
<212>  PRT
<213>  Swine


<220>
<221>  PEPTIDE
<222>  (1)..(16)
<223>  Co-stimulatory peptide domainfrom invasin

<220>
<221>  PEPTIDE
<222>  (17)..(18)
<223>  linker

<220>
<221>  PEPTIDE
<222>  (19)..(35)
<223>  MVF Th

<220>
<221>  PEPTIDE
<222>  (36)..(45)
<223>  LHRH

<400>  8

Thr Ala Lys Ser Lys Lys Phe Pro Ser Tyr Thr Ala Thr Tyr Gln Phe 
1               5                   10                  15      


Gly Gly Leu Ser Glu Ile Lys Gly Val Ile Val His Arg Leu Glu Gly 
            20                  25                  30          


Val Gly Gly Glu His Trp Ser Tyr Gly Leu Arg Pro Gly 
        35                  40                  45  


<210>  9
<211>  45
<212>  PRT
<213>  Swine


<220>
<221>  PEPTIDE
<222>  (1)..(16)
<223>  Co-stimulatory peptide domain from invasin

<220>
<221>  PEPTIDE
<222>  (17)..(18)
<223>  linker

<220>
<221>  PEPTIDE
<222>  (19)..(33)
<223>  HBsAg Th

<220>
<221>  PEPTIDE
<222>  (34)..(35)
<223>  linker

<220>
<221>  PEPTIDE
<222>  (36)..(45)
<223>  LHRH

<400>  9

Thr Ala Lys Ser Lys Lys Phe Pro Ser Tyr Thr Ala Thr Tyr Gln Phe 
1               5                   10                  15      


Gly Gly Phe Phe Leu Leu Thr Arg Ile Leu Thr Ile Pro Gln Ser Leu 
            20                  25                  30          


Glu Gly Gly Glu His Trp Ser Tyr Gly Leu Arg Pro Gly 
        35                  40                  45  


<210>  10
<211>  47
<212>  PRT
<213>  Swine


<220>
<221>  PEPTIDE
<222>  (1)..(16)
<223>  Co-stimulatory peptide domain from invasin

<220>
<221>  PEPTIDE
<222>  (17)..(17)
<223>  epsilon K as a linker

<220>
<221>  PEPTIDE
<222>  (18)..(36)
<223>  SSAL1 Th

<220>
<221>  MISC_FEATURE
<222>  (21)..(21)
<223>  S or T

<220>
<221>  MISC_FEATURE
<222>  (24)..(24)
<223>  R or K

<220>
<221>  MISC_FEATURE
<222>  (25)..(25)
<223>  T or G

<220>
<221>  MISC_FEATURE
<222>  (29)..(29)
<223>  T or H

<220>
<221>  MISC_FEATURE
<222>  (30)..(30)
<223>  K or R

<220>
<221>  PEPTIDE
<222>  (37)..(37)
<223>  epsilon K as a linker

<220>
<221>  PEPTIDE
<222>  (38)..(47)
<223>  LHRH

<400>  10

Thr Ala Lys Ser Lys Lys Phe Pro Ser Tyr Thr Ala Thr Tyr Gln Phe 
1               5                   10                  15      


Lys Ile Ser Ile Xaa Glu Ile Xaa Xaa Val Ile Val Xaa Xaa Ile Glu 
            20                  25                  30          


Thr Ile Leu Phe Lys Glu His Trp Ser Tyr Gly Leu Arg Pro Gly 
        35                  40                  45          


<210>  11
<211>  4
<212>  PRT
<213>  Homo sapiens


<220>
<221>  PEPTIDE
<222>  (4)..(4)
<223>  epsilon K

<220>
<221>  PEPTIDE
<222>  (1)..(4)
<223>  Spacer

<400> 11

Lys Lys Lys Lys
1


<210>  12
<211>  4
<212>  PRT
<213>  Homo sapiens


<220>
<221>  PEPTIDE
<222>  (1)..(1)
<223>  epsilon K

<220>
<221>  PEPTIDE
<222>  (1)..(4)
<223>  Spacer

<400>  12

Lys Lys Lys Lys
1

